Skip to main content
Caplight Logo









Arletta Pharma Solutions

Arletta Pharma Solutions

Private
AmsterdamHealthcare & Life Scienceshttps://arlettapharmasolutions.com/

Last Round

Seed

Mar 29, 2022

Total Funding Raised

$8.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Arletta Pharma Solutions is a pharmaceutical company developing innovative therapies for women diagnosed with Female Sexual Interest/Arousal Disorder (FSIAD).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

female sexual dysfunctionFSIADHSDDfemale libido drugbiotechclinical developmentpharmaceutical researchon-demand therapysexual healthwomen's healthdrug discoveryclinical trialspink pill

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arletta Pharma Solutions Comparables

Compare Arletta Pharma Solutions with similar companies based on industry and business-model similarity.

Arletta Pharma Solutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
S1 Biopharma, Inc.
81%
Azurity Pharmaceuticals
74%
JASTLabs Corp
74%

Arletta Pharma Solutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 29, 2022

Key People

Founding team and executive leadership

Nicole Hijnen

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 113% MoM.

  • Jan 28, 2025

    Manuel Voll appointed as Chairman of the Supervisory Board.

Arletta Pharma Solutions Filings

Explore SEC and related filing metadata, where available.

Arletta Pharma Solutions filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arletta Pharma Solutions's valuation, stock price, and market status.

Is Freya Pharma Solutions a public or private company?

Freya Pharma Solutions is a private company.

What is the current stock price of Freya Pharma Solutions?

Freya Pharma Solutions is a private company with no public stock price. No recent secondary market data is available.

How much is Freya Pharma Solutions worth (valuation)?

Valuation information for Freya Pharma Solutions is not publicly available.

Can I buy Freya Pharma Solutions stock?

Freya Pharma Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Freya Pharma Solutions's last funding round?

Freya Pharma Solutions's most recent funding round was Seed on March 29, 2022.

Who are the main investors in Freya Pharma Solutions?

Investor information for Freya Pharma Solutions is not publicly disclosed.

Will Freya Pharma Solutions IPO soon?

No public IPO plans have been announced for Freya Pharma Solutions.

How can I track Freya Pharma Solutions secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Freya Pharma Solutions's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range6
Year Founded2020
Last FundingMar 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?